SEC Form 4 · accession 0000921895-19-000047

ENZON PHARMACEUTICALS, INC. · ENZN

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners

Jonathan Couchman

10% Owner · Other

Xstelos Corp.

10% Owner · Other

Couchman Family Fund

10% Owner · Other

Period of report

Apr 13, 2018

Accepted (ET)

Jan 9, 2019 · 8:49 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000727510

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock, $0.01 par value^F1,F2	Apr 13, 2018	P	4,700	$0.26	A	3,582,364	D
Common Stock, $0.01 par value^F1,F2	Apr 16, 2018	P	185,700	$0.26	A	3,768,064	D
Common Stock, $0.01 par value^F1,F2	May 2, 2018	P	3,000	$0.26	A	3,771,064	D
Common Stock, $0.01 par value^F1,F2	May 7, 2018	P	33,500	$0.26	A	3,804,564	D
Common Stock, $0.01 par value^F1,F2	May 15, 2018	P	55,000	$0.26	A	3,859,564	D
Common Stock, $0.01 par value^F1,F2	May 17, 2018	P	4,000	$0.26	A	3,863,564	D
Common Stock, $0.01 par value^F1,F2	May 18, 2018	P	20,200	$0.26	A	3,883,764	D
Common Stock, $0.01 par value^F1,F2	May 21, 2018	P	50,000	$0.26	A	3,933,764	D
Common Stock, $0.01 par value^F1,F2	May 22, 2018	P	5,500	$0.26	A	3,939,264	D
Common Stock, $0.01 par value^F1,F2	Jun 4, 2018	P	1,000	$0.26	A	3,940,264	D
Common Stock, $0.01 par value^F1,F2	Jun 5, 2018	P	2,000	$0.26	A	3,942,264	D
Common Stock, $0.01 par value^F1,F2	Jun 22, 2018	P	68,195	$0.26	A	4,010,459	D
Common Stock, $0.01 par value^F1,F2	Jun 25, 2018	P	500	$0.26	A	4,010,959	D
Common Stock, $0.01 par value^F1,F2	Jun 26, 2018	P	1,120	$0.26	A	4,012,079	D
Common Stock, $0.01 par value^F1,F2	Jun 28, 2018	P	32,345	$0.26	A	4,044,424	D
Common Stock, $0.01 par value^F1,F2	Jun 29, 2018	P	1,300	$0.26	A	4,045,724	D
Common Stock, $0.01 par value^F1,F2	Jul 2, 2018	P	600	$0.26	A	4,046,324	D
Common Stock, $0.01 par value^F1,F2	Jul 3, 2018	P	20,000	$0.26	A	4,066,324	D
Common Stock, $0.01 par value^F1,F2	Jul 5, 2018	P	21,975	$0.26	A	4,088,299	D
Common Stock, $0.01 par value^F1,F2	Jul 10, 2018	P	2,800	$0.26	A	4,091,099	D
Common Stock, $0.01 par value^F1,F2	Jul 11, 2018	P	635	$0.26	A	4,091,734	D
Common Stock, $0.01 par value^F1,F2	Jul 20, 2018	P	355	$0.26	A	4,092,089	D
Common Stock, $0.01 par value^F1,F2	Jul 24, 2018	P	11,368	$0.26	A	4,103,457	D
Common Stock, $0.01 par value^F1,F2	Jul 26, 2018	P	26,655	$0.26	A	4,130,112	D
Common Stock, $0.01 par value^F1,F2	Jul 27, 2018	P	112	$0.26	A	4,130,224	D
Common Stock, $0.01 par value^F1,F2	Jul 30, 2018	P	8,255	$0.26	A	4,138,479	D
Common Stock, $0.01 par value^F1,F2	Aug 6, 2018	P	40,316	$0.26	A	4,178,795	D
Common Stock, $0.01 par value^F1,F2	Aug 10, 2018	P	9,500	$0.26	A	4,188,295	D
Common Stock, $0.01 par value^F1,F2,F3	Aug 13, 2018	P	384,100	$0.2575	A	4,572,395	D
Common Stock, $0.01 par value^F1,F2	Aug 14, 2018	P	3,671	$0.255	A	4,576,066	D

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses

F1This Form 4 is filed jointly by Jonathan Couchman ("Mr. Couchman"), Couchman Family Fund (the "Foundation") and Xstelos Corp. ("Xstelos" and, together with Mr. Couchman and the Foundation, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively owns more than 10% of the Issuer's outstanding shares of Common Stock (the "Shares"). Each of the Reporting Persons expressly disclaims beneficial ownership of the Shares reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such Shares for purposes of Section 16 or for any other purpose.
F2Due to the Securities and Exchange Commission's electronic filing system limitation of thirty line items on Table I, this Form 4 filing is part one of two.
F3The price reported is a weighted average price. These Shares were purchased in multiple transactions at prices ranging from $0.2400 to $0.2600. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the range set forth in this footnote 3.